Aurobindo gets USFDA nod for anti-depressant drug

By : BS Reporter
Last Updated: Thu, Sep 13, 2012 03:53 hrs

Hyderabad-based Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Escitalopram Oxalate tablets, indicated for treatment of depression associated with mood disorders.

More from Sify: